These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 7889636

  • 1. Effect of glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in hypopituitary adults.
    al-Shoumer KA, Beshyah SA, Niththyananthan R, Johnston DG.
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):85-90. PubMed ID: 7889636
    [Abstract] [Full Text] [Related]

  • 2. Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism.
    Al-Shoumer KA, Ali K, Anyaoku V, Niththyananthan R, Johnston DG.
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):171-8. PubMed ID: 8881449
    [Abstract] [Full Text] [Related]

  • 3. The effects of growth hormone replacement therapy on overnight metabolic fuels in hypopituitary patients.
    Kousta E, Chrisoulidou A, Lawrence NJ, Anyaoku V, Al-Shoumer KA, Johnston DG.
    Clin Endocrinol (Oxf); 2000 Jan; 52(1):17-24. PubMed ID: 10651749
    [Abstract] [Full Text] [Related]

  • 4. Growth hormone treatment in hypopituitary GH deficient adults reduces circulating cortisol levels during hydrocortisone replacement therapy.
    Rodríguez-Arnao J, Perry L, Besser GM, Ross RJ.
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):33-7. PubMed ID: 8796136
    [Abstract] [Full Text] [Related]

  • 5. The effects on insulin action in adult hypopituitarism of recombinant human GH therapy individually titrated for six months.
    McConnell EM, Atkinson AB, Ennis C, Hadden DR, McCance DR, Sheridan B, Bell PM.
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5342-7. PubMed ID: 11701703
    [Abstract] [Full Text] [Related]

  • 6. Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults.
    al-Shoumer KA, Gray R, Anyaoku V, Hughes C, Beshyah S, Richmond W, Johnston DG.
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):795-802. PubMed ID: 9713570
    [Abstract] [Full Text] [Related]

  • 7. The ketosis-resistance in fibro-calculous-pancreatic-diabetes. 1. Clinical observations and endocrine-metabolic measurements during oral glucose tolerance test.
    Yajnik CS, Shelgikar KM, Naik SS, Kanitkar SV, Orskov H, Alberti KG, Hockaday TD.
    Diabetes Res Clin Pract; 1992 Feb; 15(2):149-56. PubMed ID: 1563331
    [Abstract] [Full Text] [Related]

  • 8. Hydrocortisone replacement therapy in children and adolescents with hypopituitarism.
    DeVile CJ, Stanhope R.
    Clin Endocrinol (Oxf); 1997 Jul; 47(1):37-41. PubMed ID: 9302370
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of diabetes and impaired glucose tolerance in adult hypopituitarism on low dose oral hydrocortisone replacement therapy.
    McConnell EM, Bell PM, Hadden DR, McCance DR, Sheridan B, Atkinson AB.
    Clin Endocrinol (Oxf); 2001 May; 54(5):593-9. PubMed ID: 11380489
    [Abstract] [Full Text] [Related]

  • 10. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement.
    Swords FM, Carroll PV, Kisalu J, Wood PJ, Taylor NF, Monson JP.
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):613-20. PubMed ID: 14616886
    [Abstract] [Full Text] [Related]

  • 11. Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency.
    Agha A, Liew A, Finucane F, Baker L, O'Kelly P, Tormey W, Thompson CJ.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):688-93. PubMed ID: 15163331
    [Abstract] [Full Text] [Related]

  • 12. The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults.
    Weaver JU, Thaventhiran L, Noonan K, Burrin JM, Taylor NF, Norman MR, Monson JP.
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):639-48. PubMed ID: 7828353
    [Abstract] [Full Text] [Related]

  • 13. Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
    Florakis D, Hung V, Kaltsas G, Coyte D, Jenkins PJ, Chew SL, Grossman AB, Besser GM, Monson JP.
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):453-9. PubMed ID: 11012570
    [Abstract] [Full Text] [Related]

  • 14. Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy.
    al-Shoumer KA, Cox KH, Hughes CL, Richmond W, Johnston DG.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2653-9. PubMed ID: 9253349
    [Abstract] [Full Text] [Related]

  • 15. Lower cortisol levels after oral glucose in subjects with insulin resistance and abdominal obesity.
    Fernández-Real JM, Ricart W, Casamitjana R.
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):583-8. PubMed ID: 9425398
    [Abstract] [Full Text] [Related]

  • 16. Reproducibility of the insulin tolerance test (ITT) for assessment of growth hormone and cortisol secretion in normal and hypopituitary adult men.
    Pfeifer M, Kanc K, Verhovec R, Kocijancic A.
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):17-22. PubMed ID: 11167921
    [Abstract] [Full Text] [Related]

  • 17. Effect of breakfast fat content on glucose tolerance and risk factors of atherosclerosis and thrombosis.
    Frape DL, Williams NR, Rajput-Williams J, Maitland BW, Scriven AJ, Palmer CR, Fletcher RJ.
    Br J Nutr; 1998 Oct; 80(4):323-31. PubMed ID: 9924274
    [Abstract] [Full Text] [Related]

  • 18. Effect of obesity on circulating intermediary metabolite concentrations in the absence of impaired glucose tolerance.
    Robertson DA, Singh BM, Nattrass M.
    Int J Obes; 1991 Oct; 15(10):635-45. PubMed ID: 1752724
    [Abstract] [Full Text] [Related]

  • 19. Abnormalities of intermediary metabolism following a gestational diabetic pregnancy.
    Chan SP, Gelding SV, McManus RJ, Nicholls JS, Anyaoku V, Niththyananthan R, Johnston DG, Dornhorst A.
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):417-20. PubMed ID: 1424175
    [Abstract] [Full Text] [Related]

  • 20. Reduced circulating stem cells associate with excess fasting and post-load NEFA exposure in healthy adults with normal glucose tolerance.
    Fadini GP, Tura A, Pacini G, Avogaro A, Vigili de Kreutzenberg S.
    Atherosclerosis; 2017 Jun; 261():117-123. PubMed ID: 28298252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.